Prior Auth Required

81283 - FNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant

This procedure appears on the selected insurer prior authorization source.

Prior authorizationPrior Auth Required
Procedure / ServiceFNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant
Procedure / Service Description

Genetic and Molecular Testing Medical Necessity Guideline - 81279 JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13) 81283 FNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant 81284 FXN (frataxin) (eg, Friedreich ataxia) gene analysis; evaluation to detect abnormal (expanded) alleles

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.